240 related articles for article (PubMed ID: 30778149)
1. Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction.
Alcantara Llaguno S; Sun D; Pedraza AM; Vera E; Wang Z; Burns DK; Parada LF
Nat Neurosci; 2019 Apr; 22(4):545-555. PubMed ID: 30778149
[TBL] [Abstract][Full Text] [Related]
2. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
3. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes.
Alcantara Llaguno SR; Wang Z; Sun D; Chen J; Xu J; Kim E; Hatanpaa KJ; Raisanen JM; Burns DK; Johnson JE; Parada LF
Cancer Cell; 2015 Oct; 28(4):429-440. PubMed ID: 26461091
[TBL] [Abstract][Full Text] [Related]
4. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling.
Chen F; Rosiene J; Che A; Becker A; LoTurco J
Development; 2015 Oct; 142(20):3601-11. PubMed ID: 26400094
[TBL] [Abstract][Full Text] [Related]
5. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
6. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
7. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
8. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
[TBL] [Abstract][Full Text] [Related]
9. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
10. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
[TBL] [Abstract][Full Text] [Related]
11. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
12. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
13. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.
Banerjee S; Crouse NR; Emnett RJ; Gianino SM; Gutmann DH
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15996-6001. PubMed ID: 21896734
[TBL] [Abstract][Full Text] [Related]
15. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche.
Zou Y; Niu W; Qin S; Downes M; Burns DK; Zhang CL
Mol Cell Biol; 2012 Dec; 32(23):4811-20. PubMed ID: 23028043
[TBL] [Abstract][Full Text] [Related]
16. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model.
Wang Y; Yang J; Zheng H; Tomasek GJ; Zhang P; McKeever PE; Lee EY; Zhu Y
Cancer Cell; 2009 Jun; 15(6):514-26. PubMed ID: 19477430
[TBL] [Abstract][Full Text] [Related]
17. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.
Kang YJ; Balter B; Csizmadia E; Haas B; Sharma H; Bronson R; Yan CT
Nat Commun; 2017 Jan; 8():14013. PubMed ID: 28094268
[TBL] [Abstract][Full Text] [Related]
18. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.
Alcantara Llaguno S; Chen J; Kwon CH; Jackson EL; Li Y; Burns DK; Alvarez-Buylla A; Parada LF
Cancer Cell; 2009 Jan; 15(1):45-56. PubMed ID: 19111880
[TBL] [Abstract][Full Text] [Related]
19. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.
Lee JS; Park JR; Kwon OS; Lee TH; Nakano I; Miyoshi H; Chun KH; Park MJ; Lee HJ; Kim SU; Cha HJ
Neuro Oncol; 2015 Jan; 17(1):95-106. PubMed ID: 25096191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
